Venrock Adviser, LLC Diversified Active

Location: New York, NY

CIK: 0001615982 · Show all filings

Period: Q4 2023 (← Previous) (Next →)

Filing Date: Feb 14, 2024

Total Value: $1.458B (100.0% shares, 0.0% debt)

Holdings (36)

RAYZEBIO INC 17.2%
Value $251M Shares 4,030,471 Est. Cost $22.20 Unrealized
APGE APOGEE THERAPEUTICS INC 16.3%
Value $237M Shares 8,493,321 Est. Cost $22.03 Unrealized -9.0%
PHVS PHARVARIS N V 6.5%
Value $95.25M Shares 3,395,606 Est. Cost $15.96 Unrealized +26.7%
VRDN VIRIDIAN THERAPEUTICS INC 5.8%
Value $84.56M Shares 3,882,623 Est. Cost $19.32 Unrealized -18.3%
FDMT 4D MOLECULAR THERAPEUTICS IN 4.8%
Value $69.37M Shares 3,424,031 Est. Cost $17.76 Unrealized -25.9%
MERUS N V 4.1%
Value $59.08M Shares 2,148,214 Est. Cost $20.36 Unrealized
CABA CABALETTA BIO INC 4.0%
Value $58.2M Shares 2,563,952 Est. Cost $6.85 Unrealized +145.5%
SYRE SPYRE THERAPEUTICS INC 3.5%
Value $51.06M Shares 2,372,714 Est. Cost $13.78 Unrealized 0.0%
KALV KALVISTA PHARMACEUTICALS INC 3.4%
Value $50.14M Shares 4,092,731 Est. Cost $6.43 Unrealized +41.5%
ELVN ENLIVEN THERAPEUTICS INC 2.8%
Value $40.9M Shares 2,954,902 Est. Cost $19.48 Unrealized -37.2%
OCUL OCULAR THERAPEUTIX INC 2.4%
Value $34.68M Shares 7,775,760 Est. Cost $2.96 Unrealized 0.0%
HILLEVAX INC 2.3%
Value $33.3M Shares 2,075,000 Est. Cost $13.50 Unrealized
AMBRX BIOPHARMA INC 2.0%
Value $29.48M Shares 2,070,000 Est. Cost $14.24 Unrealized
TERN TERNS PHARMACEUTICALS INC 2.0%
Value $29.19M Shares 4,497,117 Est. Cost $4.28 Unrealized +23.6%
DYN DYNE THERAPEUTICS INC 2.0%
Value $28.91M Shares 2,173,913 Est. Cost $11.80 Unrealized -17.2%
COGT COGENT BIOSCIENCES INC 1.9%
Value $27.54M Shares 4,684,167 Est. Cost $8.79 Unrealized -12.8%
CELC CELCUITY INC 1.9%
Value $27.47M Shares 1,885,538 Est. Cost $10.24 Unrealized +18.0%
MERSANA THERAPEUTICS INC 1.8%
Value $26.28M Shares 11,328,000 Est. Cost $1.27 Unrealized
ARVN ARVINAS INC 1.8%
Value $25.84M Shares 627,788 Est. Cost $23.38 Unrealized 0.0%
ASTRIA THERAPEUTICS INC 1.7%
Value $24.77M Shares 3,225,806 Est. Cost $7.68 Unrealized
RYTM RHYTHM PHARMACEUTICALS INC 1.6%
Value $22.8M Shares 495,983 Est. Cost $18.05 Unrealized +74.8%
ORIC ORIC PHARMACEUTICALS INC 1.5%
Value $22.34M Shares 2,428,385 Est. Cost $5.86 Unrealized +23.3%
APPLIED THERAPEUTICS INC 1.4%
Value $20.94M Shares 6,250,000 Est. Cost $1.48 Unrealized
TSHA TAYSHA GENE THERAPIES INC 1.3%
Value $18.43M Shares 10,412,872 Est. Cost $1.87 Unrealized +6.7%
SVRA SAVARA INC 1.1%
Value $16.45M Shares 3,500,000 Est. Cost $1.58 Unrealized +142.8%
LYRA THERAPEUTICS INC 0.9%
Value $13.5M Shares 2,575,593 Est. Cost $5.39 Unrealized
ABVX ABIVAX SA 0.7%
Value $10.68M Shares 998,570 Est. Cost $10.70 Unrealized
DNTH DIANTHUS THERAPEUTICS INC 0.7%
Value $9.648M Shares 927,706 Est. Cost $12.62 Unrealized -12.4%
PRAX PRAXIS PRECISION MEDICINES I 0.5%
Value $7.879M Shares 353,626 Est. Cost $18.01 Unrealized 0.0%
GHRS GH RESEARCH PLC 0.5%
Value $7.646M Shares 1,318,327 Est. Cost $17.34 Unrealized -59.3%
ACELYRIN INC 0.5%
Value $6.991M Shares 937,113 Est. Cost $9.96 Unrealized
EYPT EYEPOINT PHARMACEUTICALS INC 0.4%
Value $5.777M Shares 250,000 Est. Cost $11.18 Unrealized 0.0%
TRVI TREVI THERAPEUTICS INC 0.3%
Value $4.586M Shares 3,422,397 Est. Cost $2.46 Unrealized -38.5%
ADVERUM BIOTECHNOLOGIES INC 0.3%
Value $3.875M Shares 5,147,547 Est. Cost $1.55 Unrealized
MIST MILESTONE PHARMACEUTICALS IN 0.1%
Value $1.545M Shares 925,048 Est. Cost $7.58 Unrealized -64.2%
OLMA OLEMA PHARMACEUTICALS INC 0.1%
Value $1.081M Shares 77,042 Est. Cost $10.19 Unrealized +31.8%